Early Access | Alkermes

About Us

About Alkermes

Our Company Message From the CEO Locations

Leadership

Management Team Board of Directors

Collaborations

Strategic Partners

Products

Products Overview

United States

ARISTADA^® VIVITROL^® Proprietary Products and Technologies Wholesaler and Purchasing Information

European Union

EU Products Using Alkermes Technologies

Research & Development

R&D Overview Our R&D Approach Pipeline Technology Platforms Manufacturing

Other Information

Clinical Trials Early Access Investigator Sponsored Studies

Responsibility

Corporate Responsibility Corporate Giving and Funding Alkermes Inspiration Grants^® COVID-19 Relief Fund Medical Education Grants Alkermes Pathways Research Awards^® Investigator Sponsored Studies Public Policy

Investors

Corporate Overview Press Releases Investor Events Stock Information SEC Filings Annual Reports

Financials

Snapshot Trading Statistics

Other Information

Email Alerts

News & Events

Press Releases Media Kit

Careers

Working Together Our Core Values Total Rewards Meet Our Employees Recruiting Agencies Equal Opportunity Employer Jobs Overview

Job Opportunities

Field Sales Roles All Available Roles

Early Access

If you are interested in access to an Alkermes investigational therapy, please read the Alkermes Early Access Policy, a copy of which may be found here.